NVRO Logo

Nevro Corp. (NVRO) 

NYSE
Market Cap
$166.19M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
641 of 774
Rank in Industry
82 of 99

Largest Insider Buys in Sector

NVRO Stock Price History Chart

NVRO Stock Performance

About Nevro Corp.

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and …

Insider Activity of Nevro Corp.

Over the last 12 months, insiders at Nevro Corp. have bought $0 and sold $0 worth of Nevro Corp. stock.

On average, over the past 5 years, insiders at Nevro Corp. have bought $1.14M and sold $17.11M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 7,500 shares for transaction amount of $171,633 was made by McCormick Shawn (director) on 2023‑06‑07.

List of Insider Buy and Sell Transactions, Nevro Corp.

2023-06-07Purchasedirector
7,500
0.0209%
$22.88$171,633-24.78%
2022-05-09PurchaseGeneral Counsel
2,250
0.0065%
$44.50$100,126-4.90%
2022-03-11PurchaseGeneral Counsel
1,500
0.0043%
$64.04$96,067-31.50%
2022-03-08PurchaseChairman, President & CEO
3,200
0.0089%
$63.59$203,488-32.38%
2021-12-14Purchasedirector
2,400
0.0069%
$83.78$201,070-42.69%
2021-11-22Purchasedirector
20,000
0.0577%
$85.33$1.71M-42.12%
2021-11-11PurchaseGeneral Counsel
2,000
0.006%
$101.05$202,100-47.57%
2021-08-13PurchaseChairman, President & CEO
7,000
0.0207%
$105.07$735,490-28.39%
2021-06-22Saledirector
6,445
0.0186%
$179.03$1.15M-51.46%
2021-05-24Saledirector
482
0.0014%
$149.65$72,131-38.06%
2021-03-10SaleChief Commercial Officer
750
0.0022%
$148.08$111,060-18.14%
2021-03-01Saledirector
5,303
0.0151%
$167.84$890,039-28.62%
2021-02-10SaleChief Commercial Officer
750
0.0022%
$182.55$136,913-31.59%
2021-01-11SaleChief Commercial Officer
750
0.0022%
$169.80$127,350-14.71%
2020-12-10SaleChief Commercial Officer
750
0.0021%
$161.21$120,910-10.56%
2020-11-10SaleChief Commercial Officer
750
0.0022%
$170.75$128,063-10.19%
2020-10-22SaleChief Commercial Officer
1,817
0.0054%
$165.00$299,805-5.39%
2020-10-19SaleChief Commercial Officer
1,000
0.003%
$155.00$155,000+1.72%
2020-10-13SaleChief Commercial Officer
750
0.0022%
$151.47$113,603+1.22%
2020-10-12Saledirector
903
0.0026%
$151.21$136,543+1.31%

Insider Historical Profitability

11.39%
Novo A/S10 percent owner
2194841
5.8573%
$4.4410+85.38%
JOHNSON & JOHNSON10 percent owner
2066740
5.5155%
$4.4411+85.38%
GROSSMAN D KEITHChairman, President & CEO
169290
0.4518%
$4.4420<0.0001%
Rashid KashifGeneral Counsel
53526
0.1428%
$4.4430<0.0001%
WEATHERMAN ELIZABETH Hdirector
38328
0.1023%
$4.4430+32.35%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Armistice Capital Llc$52.33M9.873.62M+14.11%+$6.47M0.17
BlackRock$49.3M9.33.41M+1.2%+$583,765.90<0.01
The Vanguard Group$45.83M8.643.17M-21.96%-$12.9M<0.01
Arrowmark Colorado Holdings Llc$40.37M7.612.8M-7.15%-$3.11M0.1
Alger$30.09M5.672.08M-1.68%-$513,760.760.15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.